AVITA Medical (RCEL) Stock Price, News & Analysis

Company Overview

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Key Stats

• Today's Range: $12.53 to $13.19
• 50-Day Range: $8.84 to $12.87
• 52-Week Range: $7.51 to $18.93
• Volume: 160,944 shs
• Average Volume: 183,089 shs
• Market Capitalization: $329.82 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.50
• Consensus Rating: Hold

AVITA Medical Stock Analysis - MarketRank™

AVITA Medical scored higher than 39% of companies evaluated by MarketBeat, and ranked 755th out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

AVITA Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

AVITA Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for AVITA Medical are expected to grow in the coming year, from ($2.28) to ($1.30) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of AVITA Medical is -5.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of AVITA Medical is -5.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

AVITA Medical has a P/B Ratio of 27.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.83% of the float of AVITA Medical has been sold short.

Short Interest Ratio / Days to Cover

AVITA Medical has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.

Change versus previous month

Short interest in AVITA Medical has recently decreased by 11.19%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

AVITA Medical does not currently pay a dividend.

Dividend Growth

AVITA Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.83% of the float of AVITA Medical has been sold short.

Short Interest Ratio / Days to Cover

AVITA Medical has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.

Change versus previous month

Short interest in AVITA Medical has recently decreased by 11.19%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.08

News Sentiment

AVITA Medical has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for AVITA Medical this week, compared to 1 article on an average week.

Search Interest

5 people have searched for RCEL on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, AVITA Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.82% of the stock of AVITA Medical is held by insiders.

Percentage Held by Institutions

Only 27.66% of the stock of AVITA Medical is held by institutions.

RCEL Stock Analysis - Frequently Asked Questions

How have RCEL shares performed this year?

AVITA Medical's stock was trading at $13.72 at the beginning of the year. Since then, RCEL stock has decreased by 7.5% and is now trading at $12.69.
View the best growth stocks for 2024 here.

How were AVITA Medical's earnings last quarter?

AVITA Medical, Inc. (NASDAQ:RCEL) issued its earnings results on Thursday, November, 7th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.21. The firm had revenue of $19.55 million for the quarter, compared to analysts' expectations of $19.65 million. AVITA Medical had a negative trailing twelve-month return on equity of 194.69% and a negative net margin of 95.47%.

Who are AVITA Medical's major shareholders?

Top institutional investors of AVITA Medical include Essex Investment Management Co. LLC (0.90%), Quest Partners LLC (0.03%), FMR LLC (0.02%) and Huntington National Bank (0.01%). Insiders that own company stock include Michael S Perry, Donna Shiroma, Jeremy Curnock Cook and James Corbett.
View institutional ownership trends.

How do I buy shares of AVITA Medical?

Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of AVITA Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AVITA Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD) and Tesla (TSLA).

Company Calendar

• Last Earnings: 11/07/2024
• Today: 11/14/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 2/27/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:RCEL
• CUSIP: N/A
• CIK: 1762303
• Web: www.avitamedical.com
• Phone: (833) 462-8482
• Fax: N/A
• Employees: 130
• Year Founded: 2008

Price Target and Rating

• Average Stock Price Target: $16.50
• High Stock Price Target: $21.00
• Low Stock Price Target: $12.00
• Potential Upside/Downside: +26.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($2.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-35,380,000.00
• Net Margins: -95.47%
• Pretax Margin: -95.39%
• Return on Equity: -194.69%
• Return on Assets: -60.67%

Debt

• Debt-to-Equity Ratio: 3.48
• Current Ratio: 3.73
• Quick Ratio: 4.81

Sales & Book Value

• Annual Sales: $50.14 million
• Price / Sales: 6.83
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.47 per share
• Price / Book: 27.81

Miscellaneous

• Outstanding Shares: 26,220,000
• Free Float: 25,741,000
• Market Cap: $342.70 million
• Optionable: Optionable
• Beta: 1.54